/ /

Lisette Hilton
Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.
New neurotoxin on the block starts phase 3 trials
The injectable neurotoxin drug candidate daxibotulinumtoxinA for injection (RT002, Revance Therapeutics) started phase 3 SAKURA trials in December 2016
RF microneedling applications
One dermatologists describes her success with radiofreqency microneedling to treat acne and acne scarring.
What cellulite? Cellfina leads the way
Cellfina is subscision of the fibrous attachments between the skin and fat layers. It is the only FDA-cleared device to have solid three-year data showing that the cellulite doesn’t come back, expert says.
The Skinny on fat reduction, cellulite devices
Fresh after her presentations on fat reduction and cellulite treatment devices at ASDS, Sue Ellen Cox, M.D., offers unplugged advice about today’s technologies.
'Dr. Scar' shares treatment pearls
A U.S. dermatologist shares his experience working with a Chinese plastic surgeon who does a high-volume of scar treatments.
FDA approves corticosteroid-sparing topical option for eczema
The FDA announced it has approved Eucrisa (Anacor Pharmaceuticals, crisaborole) ointment to treat mild to moderate eczema in patients two-years-of-age and older.
Motivating teens not to tan, on teens’ terms
You might be surprised about what researchers have uncovered about why teens tan. Having a better understanding of their motives, could help you help them.
Responding to melanoma’s growing threat
Melanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology.
How the Trump presidency may impact dermatology
Dermatology’s leaders share perspectives on how the new Administration may impact medicine.
Dermatology’s 2017 Game Changers
Several dermatologists go over what they're most excited about to see in 2017 in a number of different topics ranging from AD treatment to off-label technology use, to more male patients.

Poll

View Results